Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL

Insulin lispro 200 U/mL (IL200) is a new strength formulation of insulin lispro (Humalog®, IL100), developed as an option for diabetic patients on higher daily mealtime insulin doses. This phase 1, open‐label, 2‐sequence, 4‐period crossover, randomized, 8‐hour euglycemic clamp study aimed to demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Peña, Amparo, Seger, Mary, Soon, Danny, Scott, Adam J., Reddy, Shobha R., Dobbins, Michael A., Brown‐Augsburger, Patricia, Linnebjerg, Helle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054907/
https://www.ncbi.nlm.nih.gov/pubmed/27119580
http://dx.doi.org/10.1002/cpdd.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054907/
https://www.ncbi.nlm.nih.gov/pubmed/27119580
http://dx.doi.org/10.1002/cpdd.221

Ejemplares similares